Cancer research demands a comprehensive understanding of how various tumor types respond to therapeutic interventions. At Creative Biolabs, our tumor cell panel screening service is designed to address this need by providing a diverse selection of tumor cell lines representing a broad spectrum of cancer types, including breast, lung, colon, prostate, and more. Our carefully curated panel of cancer cell lines mirrors the heterogeneity of human tumors, making it an invaluable resource for researchers focused on screening potential anticancer compounds or investigating the molecular mechanisms driving cancer progression.

Comprehensive Cancer Cell Panel Screening Solution

• Comprehensive Cancer Cell Line Selection

Creative Biolabs offers access to a vast collection of over 600 cancer cell lines, encompassing more than 100 that are genetically modified or drug-resistant. We provide tailored panel options for specific targets such as KRAS, DDR, and HER2, ensuring the flexibility needed to meet various research objectives. Our cell lines, sourced globally, provide a robust foundation for comprehensive cancer research.

• Diverse Assay Offerings and Flexibility

Our screening service includes a wide range of assays to measure cell viability, using both 2D and 3D cell assays for precise determination of IC50/GI50 values. Beyond viability studies, we offer colony formation, apoptosis, and cell cycle analysis assays, thereby supporting extensive research needs without time limitations. Whether your study necessitates short-term toxicity assessments or long-term efficacy evaluations, Creative Biolabs design assays with optimal flexibility in mind.

• Customized Screening

Creative Biolabs offers custom cell panels to study the precise mechanisms of action of your compound or validate its efficacy in a specific cancer type. With a commitment to flexibility and precision, these panels allow researchers to select from an extensive portfolio of cancer cell lines based on individual study requirements and a variety of assays including cell viability assays, apoptosis assays, gene expression profiling, and more.

• High-throughput Screening

Creative Biolabs uses state-of-the-art technologies to perform high-throughput screening, allowing for the efficient testing of multiple compounds across the entire panel. Our automated systems ensure that your compounds are tested in a reproducible, scalable, and efficient manner, enabling rapid data collection and minimizing experimental variability.

• Assay Conditions and Deliverables

Our assays are conducted under meticulously standardized conditions, ensuring high reproducibility and reliability of results. Assay setups can be customized for various formats, including 96-well or 384-well plates, with flexible serum concentrations. We offer a comprehensive dataset including quality control metrics, dose-response curves, and detailed experimental results.

Why Choose Us

• Access to 600+ diverse tumor cell lines, including drug-resistant and genetically engineered models covering major cancer types such as breast, lung, colon, and prostate.
• Flexible assay formats including 2D/3D viability assays, apoptosis, colony formation, and cell cycle analysis support both short- and long-term studies.
• High-throughput, automated screening ensures consistent, scalable, and reproducible data generation.
• Customized panels tailored to specific targets (e.g., KRAS, HER2, DDR) enable precise evaluation of drug efficacy and mechanism of action.
• Standardized experimental conditions and detailed data outputs including QC metrics and dose-response curves enhance data reliability and decision-making.

For more information or to discuss potential collaborations, please reach out to our team of experts. Creative Biolabs is here to provide tailored solutions for your drug discovery and development needs.

For Research Use Only | Not For Clinical Use